245 related articles for article (PubMed ID: 17963808)
1. Subchronic effects of valproic acid on gene expression profiles for lipid metabolism in mouse liver.
Lee MH; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2008 Feb; 226(3):271-84. PubMed ID: 17963808
[TBL] [Abstract][Full Text] [Related]
2. Gene expression profiles of murine fatty liver induced by the administration of valproic acid.
Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicol Appl Pharmacol; 2007 Apr; 220(1):45-59. PubMed ID: 17292431
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of murine fatty liver induced by the administration of methotrexate.
Lee MH; Hong I; Kim M; Lee BH; Kim JH; Kang KS; Kim HL; Yoon BI; Chung H; Kong G; Lee MO
Toxicology; 2008 Jul; 249(1):75-84. PubMed ID: 18502557
[TBL] [Abstract][Full Text] [Related]
4. Hepatic gene expression profiling and lipid homeostasis in mice exposed to steatogenic drug, tetracycline.
Yin HQ; Kim M; Kim JH; Kong G; Lee MO; Kang KS; Yoon BI; Kim HL; Lee BH
Toxicol Sci; 2006 Nov; 94(1):206-16. PubMed ID: 16917069
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models.
Vitins AP; Kienhuis AS; Speksnijder EN; Roodbergen M; Luijten M; van der Ven LT
Arch Toxicol; 2014 Aug; 88(8):1573-88. PubMed ID: 24535564
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice.
Yin HQ; Kim M; Kim JH; Kong G; Kang KS; Kim HL; Yoon BI; Lee MO; Lee BH
Toxicol Appl Pharmacol; 2007 Sep; 223(3):225-33. PubMed ID: 17655900
[TBL] [Abstract][Full Text] [Related]
7. The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.
Lee MS; Lee YJ; Kim BJ; Shin KJ; Chung BC; Baek DJ; Jung BH
Arch Pharm Res; 2009 Jul; 32(7):1029-35. PubMed ID: 19641884
[TBL] [Abstract][Full Text] [Related]
8. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.
Tang W; Borel AG; Fujimiya T; Abbott FS
Chem Res Toxicol; 1995; 8(5):671-82. PubMed ID: 7548749
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats.
Tong V; Teng XW; Chang TK; Abbott FS
Toxicol Sci; 2005 Aug; 86(2):427-35. PubMed ID: 15858223
[TBL] [Abstract][Full Text] [Related]
11. Association between the perturbation of bile acid homeostasis and valproic acid-induced hepatotoxicity.
Chen Y; Zhou J; Xu S; Liu M; Wang M; Ma Y; Zhao M; Wang Z; Guo Y; Zhao L
Biochem Pharmacol; 2019 Dec; 170():113669. PubMed ID: 31628911
[TBL] [Abstract][Full Text] [Related]
12. Ether-phosphatidylcholine characterized by consolidated plasma and liver lipidomics is a predictive biomarker for valproic acid-induced hepatic steatosis.
Goda K; Saito K; Muta K; Kobayashi A; Saito Y; Sugai S
J Toxicol Sci; 2018; 43(6):395-405. PubMed ID: 29877216
[TBL] [Abstract][Full Text] [Related]
13. Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices.
Szalowska E; van der Burg B; Man HY; Hendriksen PJ; Peijnenburg AA
PLoS One; 2014; 9(1):e86795. PubMed ID: 24489787
[TBL] [Abstract][Full Text] [Related]
14. Role of Nrf2 activation and NF-κB inhibition in valproic acid induced hepatotoxicity and in diammonium glycyrrhizinate induced protection in mice.
Jin J; Xiong T; Hou X; Sun X; Liao J; Huang Z; Huang M; Zhao Z
Food Chem Toxicol; 2014 Nov; 73():95-104. PubMed ID: 25152329
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility.
El-Mowafy AM; Abdel-Dayem MA; Abdel-Aziz A; El-Azab MF; Said SA
Biochim Biophys Acta; 2011; 1811(7-8):460-7. PubMed ID: 21571092
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review.
Silva MF; Aires CC; Luis PB; Ruiter JP; IJlst L; Duran M; Wanders RJ; Tavares de Almeida I
J Inherit Metab Dis; 2008 Apr; 31(2):205-16. PubMed ID: 18392741
[TBL] [Abstract][Full Text] [Related]
17. Toxicogenomic analysis of the gene expression changes in rat liver after a 28-day oral Tripterygium wilfordii multiglycoside exposure.
Zhang Y; Jiang Z; Xue M; Zhang S; Wang Y; Zhang L
J Ethnopharmacol; 2012 May; 141(1):170-7. PubMed ID: 22366672
[TBL] [Abstract][Full Text] [Related]
18. Hepatic gene expression and lipid homeostasis in C57BL/6 mice exposed to hydrazine or acetylhydrazine.
Richards VE; Chau B; White MR; McQueen CA
Toxicol Sci; 2004 Nov; 82(1):318-32. PubMed ID: 15282401
[TBL] [Abstract][Full Text] [Related]
19. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of valproic acid in mice with decreased plasma and tissue carnitine stores.
Knapp AC; Todesco L; Beier K; Terracciano L; Sägesser H; Reichen J; Krähenbühl S
J Pharmacol Exp Ther; 2008 Feb; 324(2):568-75. PubMed ID: 17986647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
